Used as a key intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the development of selective COX-2 inhibitors. Its structure supports the optimization of pharmacokinetic properties in drug candidates, such as improved metabolic stability and oral bioavailability. Commonly employed in medicinal chemistry for constructing isoxazole-based bioactive molecules with anti-inflammatory, analgesic, and antipyretic activities. Also utilized in research settings to explore structure-activity relationships (SAR) in heterocyclic compounds targeting inflammatory pathways.